A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation

Experimental Hematology

Volumn 33, Issue 8, 2005, Pages 912-919

  Broers, Annoek E C ^a   Van Der Holt, Bronno ^a   Haze, Sebastiaan ^a   Braakman, Eric ^a   Gratama, Jan Willem ^a   Löwenberg, Bob ^a   Cornelissen, Jan J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; INFECTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MICROORGANISM; MORBIDITY; MORTALITY; NEUTROPHIL; OUTCOMES RESEARCH; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; T CELL DEPLETION;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HUMANS; INCIDENCE; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 22144466581     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.05.005     Document Type: Article

References (24)

1. A. Urbano-Ispizua, N. Schmitz, and T. De Witte Allogeneic and autologous transplantation for hematological diseases, solid tumors and immune disorders: definitions and current practice in Europe Bone Marrow Transplant 29 2002 639 646
2. N. Schmitz, and J. Barret Optimizing engraftment, source and dose of stem cells Semin Hematol 39 2002 3 14
3. P. Guardiola, V. Runde, and A. Bacigalupo Retrospective comparison of bone marrow and granulocyte colony stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes Blood 99 2002 4370 4378
4. N. Schmitz, M. Beksac, and D. Hasenclever Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia Blood 100 2002 761 767
5. H.D. Ottinger, D.W. Beelen, B. Scheulen, U.W. Schaefer, and H. Gross-Wilde Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow Blood 88 1996 2775 2779
6. J. Storek, M.A. Dawson, and B. Storer Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood 97 2001 3380 3389
7. L. Ochs, X.O. Shu, and J. Miller Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients Blood 86 1995 3979 3986
8. +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies Exp Hematol 31 2003 855 864
9. H. Glucksberg, R. Storb, and A. Fefer Clinical manifestations of graft-vs-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 18 1974 295 304
10. J.W. Van Esser, B. Van der Holt, and E. Meijer Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell depleted SCT Blood 98 2001 972 978
11. J.W. Van Esser, H.G. Niesters, and B. Van der Holt Prevention of Epstein-Barr virus lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation Blood 99 2002 4364 4369
12. J.K. Nicholson, M. Hubbard, and B.M. Jones Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry Cytometry 26 1996 16 21
13. + T lymphocytes using tetramer technology and single-platform absolute T-cell counting J Biol Regul Homeost Agents 17 2003 268 278
14. + T-lymphocyte regeneration after intensive chemotherapy New Engl J Med 332 1995 143 149
15. S.R. Lewin, G. Heller, and L. Zhang Direct evidence of new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations Blood 100 2002 2235 2242
16. J. Storek, T. Gooley, R.P. Witherspoon, K.M. Sullivan, and R. Storb Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts Am J Hematol 54 1997 131 138
17. T.N. Small, E.B. Papadopoulos, and F. Boulad Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions Blood 93 1999 467 480
18. D. Anderson, T. DeFor, and L. Burns A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections Biol Blood Marrow Transplant 9 2003 52 59
19. P.R. Fallen, L. McGreavey, and J.A. Madrigal Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients Bone Marrow Transplant 32 2003 1001 1014
20. K.W. Weinberg, B.R. Blazar, and J.E. Wagner Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation Blood 97 2001 1458 1466
21. E. Jantunen, P. Ruutu, and L. Niskanen Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplant 19 1997 801 808
22. J.R. Wingard Fungal infections after bone marrow transplant Biol Blood Marrow Transplant 5 1999 55 68
23. R. Martino, M. Subira, and M. Rovira Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients Br J Haematol 116 2002 475 482
24. S. Braedel, M. Radsak, and H. Einsele Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4 Br J Haematol 125 2004 392 399